Canada
· Delayed Price · Currency is CAD NuGen Medical Devices Statistics
Total Valuation
TSXV:NGMD has a market cap or net worth of CAD 14.76 million. The enterprise value is 25.62 million.
| Market Cap | 14.76M |
| Enterprise Value | 25.62M |
Important Dates
The last earnings date was Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:NGMD has 227.04 million shares outstanding. The number of shares has increased by 27.89% in one year.
| Current Share Class | 227.04M |
| Shares Outstanding | 227.04M |
| Shares Change (YoY) | +27.89% |
| Shares Change (QoQ) | +0.99% |
| Owned by Insiders (%) | 2.77% |
| Owned by Institutions (%) | n/a |
| Float | 220.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.61 |
| PB Ratio | -2.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.90 |
| EV / Sales | 25.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.42 |
Financial Position
The company has a current ratio of 5.84
| Current Ratio | 5.84 |
| Quick Ratio | 5.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.77 |
| Interest Coverage | -49.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -32.49% |
| Return on Invested Capital (ROIC) | -35.90% |
| Return on Capital Employed (ROCE) | -44.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.10 |
| Inventory Turnover | 1.84 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is 2.56, so TSXV:NGMD's price volatility has been higher than the market average.
| Beta (5Y) | 2.56 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 48.28 |
| Average Volume (20 Days) | 195,617 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:NGMD had revenue of CAD 1.01 million and -5.23 million in losses. Loss per share was -0.02.
| Revenue | 1.01M |
| Gross Profit | 521,937 |
| Operating Income | -5.16M |
| Pretax Income | -5.22M |
| Net Income | -5.23M |
| EBITDA | -4.51M |
| EBIT | -5.16M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 6.95 million in cash and 17.80 million in debt, giving a net cash position of -10.86 million or -0.05 per share.
| Cash & Cash Equivalents | 6.95M |
| Total Debt | 17.80M |
| Net Cash | -10.86M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | -5.67M |
| Book Value Per Share | -0.03 |
| Working Capital | 6.47M |
Cash Flow
In the last 12 months, operating cash flow was -4.71 million and capital expenditures -10,375, giving a free cash flow of -4.72 million.
| Operating Cash Flow | -4.71M |
| Capital Expenditures | -10,375 |
| Free Cash Flow | -4.72M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | 51.68% |
| Operating Margin | -510.70% |
| Pretax Margin | -516.80% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:NGMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.89% |
| Shareholder Yield | -27.89% |
| Earnings Yield | -35.41% |
| FCF Yield | -32.01% |
Stock Splits
The last stock split was on November 8, 2021. It was a reverse split with a ratio of 0.5.
| Last Split Date | Nov 8, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |